Familial Combined Pituitary Hormone Deficiency by a Mutation in PROP1 – a Case Report

Ivona Butorac Ahel, S. Severinski, Iva Bilić Čače
{"title":"Familial Combined Pituitary Hormone Deficiency by a Mutation in PROP1 – a Case Report","authors":"Ivona Butorac Ahel, S. Severinski, Iva Bilić Čače","doi":"10.5457/p2005-114.350","DOIUrl":null,"url":null,"abstract":"Objective This paper aimed to emphasize the importance of considering the diagnosis of PROP1 mutation in all cases where multiple members of the same family are affected by combined pituitary hormone deficiencies (CPHD).Case Report − We describe two brothers of unrelated parents with a mutation in the PROP1 gene. Both brothers presented with growth impairment - the older one at the age of 2.5 years, and the younger one at the age of 3.3 years. Central hypothyroidism and GH deficiency were established in both of them. Replacement therapy was started using levothyroxine and recombinant growth hormone. Pituitary magnetic resonance imaging was normal. Genetic analysis identified a pathogenic homozygous frameshift variant c.301_302delAG in the PROP1 gene.Conclusion − Patients with PROP1 mutation must be closely followed up to reveal other possible hormonal defects and to avoid possible life-threatening adrenal crisis in the future. PROP1 mutation should be considered in all familial forms of CPHD and in all patients who have a deficiency of two or more pituitary hormones.","PeriodicalId":36516,"journal":{"name":"Central European Journal of Paediatrics","volume":"78 8","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Central European Journal of Paediatrics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5457/p2005-114.350","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Objective This paper aimed to emphasize the importance of considering the diagnosis of PROP1 mutation in all cases where multiple members of the same family are affected by combined pituitary hormone deficiencies (CPHD).Case Report − We describe two brothers of unrelated parents with a mutation in the PROP1 gene. Both brothers presented with growth impairment - the older one at the age of 2.5 years, and the younger one at the age of 3.3 years. Central hypothyroidism and GH deficiency were established in both of them. Replacement therapy was started using levothyroxine and recombinant growth hormone. Pituitary magnetic resonance imaging was normal. Genetic analysis identified a pathogenic homozygous frameshift variant c.301_302delAG in the PROP1 gene.Conclusion − Patients with PROP1 mutation must be closely followed up to reveal other possible hormonal defects and to avoid possible life-threatening adrenal crisis in the future. PROP1 mutation should be considered in all familial forms of CPHD and in all patients who have a deficiency of two or more pituitary hormones.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
因 PROP1 基因突变导致的家族性合并垂体激素缺乏症--病例报告
病例报告 - 我们描述了两兄弟的情况,他们的父母没有血缘关系,但他们的 PROP1 基因都发生了突变。兄弟俩都出现了生长障碍,哥哥在 2.5 岁时出现,弟弟在 3.3 岁时出现。两人都患有中枢性甲状腺功能减退症和 GH 缺乏症。开始使用左甲状腺素和重组生长激素进行替代治疗。垂体磁共振成像正常。结论 - PROP1基因突变的患者必须接受密切随访,以发现其他可能的激素缺陷,避免将来出现危及生命的肾上腺危象。所有家族性肾上腺皮质功能减退症患者以及所有缺乏两种或两种以上垂体激素的患者都应考虑 PROP1 基因突变。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Central European Journal of Paediatrics
Central European Journal of Paediatrics Medicine-Pediatrics, Perinatology and Child Health
CiteScore
0.50
自引率
0.00%
发文量
23
期刊最新文献
Knowledge and Attitudes toward Vaccination in Croatian Adolescents, the Influence of the Internet Foreign Body in the Main Bronchus: Radiological Signs, Complications, and Differential Diagnosis PEER REVIEWERS FOR THE CENTRAL EUROPEAN JOURNAL OF PAEDIATRICS VOL. 19. A Miraculous Rescue of Two Siblings from the Earthquake Rubble in Türkiye Assessment of Physical Condition in Cystic Fibrosis Patients during 12-month Treatment with Cystic Fibrosis Transmembrane Conductance Regulator Modulators
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1